MKM Partners recently released a bullish note on Alibaba (BABA) stock with a Street-high $280 price target, implying more than 40% upside from current levels. We largely agree with MKM’s bull thesis on Alibaba, and further believe that near-term margin concerns are unnecessarily short-sighted, while big picture investors would be wise to focus on the company’s accelerating top-line growth narrative.
Overall, we feel that BABA stock remains materially undervalued below $200. Given peer valuations and intrinsic earnings growth potential, we believe that BABA stock can easily rally to and above $230 this year, while also maintaining the view that prices above $250 are achievable.
BABA data by YCharts
Hot Undervalued Stocks To Invest In 2019: Imprimis Pharmaceuticals, Inc.(IMMY)
- [By Lisa Levin] Gainers
Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st
- [By Stephan Byrd]
Headlines about Imprimis Pharmaceuticals (NASDAQ:IMMY) have been trending positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Imprimis Pharmaceuticals earned a daily sentiment score of 0.25 on Accern’s scale. Accern also gave media headlines about the specialty pharmaceutical company an impact score of 47.393314841388 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
- [By Lisa Levin] Gainers
Boot Barn Holdings, Inc. (NYSE: BOOT) rose 15.6 percent to $25.40 in pre-market trading after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
Abaxis, Inc. (NASDAQ: ABAX) rose 15.3 percent to $82.75 in pre-market trading. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) rose 12.6 percent to $8.95 in pre-market trading after reporting Q1 results.
Micro Focus International plc (NYSE: MFGP) shares rose 8.8 percent to $18.59 in the pre-market trading session after the company issued strong revenue forecast for the first fiscal half of 2018.
HC2 Holdings, Inc. (NASDAQ: HCHC) rose 5.6 percent to $6.60 in pre-market trading.
Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares rose 5.3 percent to $2.79 in pre-market trading. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) rose 5.2 percent to $2.52 in pre-market trading after reporting a first-quarter sales beat.
Red Violet, Inc. (NASDAQ: RDVT) rose 4.1 percent to $10.35 in pre-market trading after climbing 75.31 percent on Tuesday.
Xenon Pharmaceuticals Inc (NASDAQ: XENE) rose 3.8 percent to $6.90 in pre-market trading. The stock rose over 10 percent Tuesday after reporting its Phase 1 clinical update on XEN901 demonstrated a favorable PK profile.
Sea Limited (NYSE: SE) rose 3.5 percent to $11.01 in pre-market trading after reporting Q1 results.
Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares rose 3.4 percent to $20.98 in pre-market trading after Buffett's Berkshire more than doubled its stake in Teva.
China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares rose 3.7 percent to $31.30 in pre-market trading after the company reported results for its fourth quarter.
PetIQ Inc (NASDAQ: PETQ) shares rose 3.4 percent to $20.00 in pre-market t
Hot Undervalued Stocks To Invest In 2019: John B. Sanfilippo & Son, Inc.(JBSS)
- [By Max Byerly]
John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) shares reached a new 52-week high and low during trading on Wednesday . The stock traded as low as $71.43 and last traded at $70.96, with a volume of 1305 shares trading hands. The stock had previously closed at $69.72.
- [By Stephan Byrd]
WINTON GROUP Ltd acquired a new position in shares of John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) in the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 21,466 shares of the company’s stock, valued at approximately $1,242,000. WINTON GROUP Ltd owned about 0.19% of John B. Sanfilippo & Son at the end of the most recent quarter.
- [By Joseph Griffin]
BidaskClub upgraded shares of John B. Sanfilippo & Son (NASDAQ:JBSS) from a hold rating to a buy rating in a research note released on Wednesday.
- [By Max Byerly]
The Hershey (NYSE: HSY) and John B. Sanfilippo & Son (NASDAQ:JBSS) are both consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.
Hot Undervalued Stocks To Invest In 2019: Integrated Electrical Services Inc.(IESC)
- [By Shane Hupp]
Gendell Jeffrey L decreased its stake in shares of IES Holdings Inc (NASDAQ:IESC) by 0.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,319,064 shares of the technology company’s stock after selling 36,081 shares during the period. IES comprises 21.0% of Gendell Jeffrey L’s portfolio, making the stock its largest holding. Gendell Jeffrey L owned about 0.58% of IES worth $186,634,000 as of its most recent filing with the Securities & Exchange Commission.
Hot Undervalued Stocks To Invest In 2019: ThyssenKrupp AG (TYEKF)
- [By ]
United Technologies’ Otis division manufactures and services elevators, escalators, and other people moving devices. The business is reasonably attractive since there is a fair degree of concentration. Four major companies, Kone Oyj (OTCPK:KNYJF) (OTCPK:KNYJY), ThyssenKrupp (OTCPK:TYEKF) (OTCPK:TKAMY), Schindler (OTCPK:SHLAF) (OTC:SHNDY), and Otis, account for over 50% market share. The main long-term drivers of the industry are urbanization. As you might guess, elevator demand is strongest in dense urban environments where almost every building is multi-story.
Hot Undervalued Stocks To Invest In 2019: PRA Group, Inc.(PRAA)
- [By Logan Wallace]
Carillon Tower Advisers Inc. raised its stake in PRA Group (NASDAQ:PRAA) by 706.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 84,032 shares of the business services provider’s stock after buying an additional 73,617 shares during the quarter. Carillon Tower Advisers Inc. owned about 0.19% of PRA Group worth $3,193,000 at the end of the most recent quarter.
- [By Dan Caplinger]
Like many businesses, debt collection is a cyclical industry, and as a major player in that industry, PRA Group (NASDAQ:PRAA) is subject to the ups and downs of the economy. During good times, there aren’t as many nonperforming loans for PRA Group to collect on. Only when times get tough do default rates move higher, spurring many creditors to turn their collections over to PRA.
- [By Ethan Ryder]
PRA Group (NASDAQ:PRAA) was upgraded by equities researchers at BidaskClub from a “sell” rating to a “hold” rating in a report released on Monday.